Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
May 02, 2024 09:15 ET
|
Virios Therapeutics
ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat...
Motorsport Games to Report First Quarter 2024 Financial Results
May 02, 2024 09:00 ET
|
Motorsport Games Inc.
Motorsport Games to is scheduled to report Q1 2024 financial results on May 7 2024 after market
Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
May 02, 2024 08:03 ET
|
Longeveron
Longeveron to report Q1 2024 financial results on May 14, 2024.
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
May 02, 2024 08:00 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide...
Agios Reports Business Highlights and First Quarter 2024 Financial Results
May 02, 2024 07:00 ET
|
Agios Pharmaceuticals, Inc.
– Topline Data Readout from the Phase 3 ENERGIZE-T Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia now expected in Q2 2024 – – Announced Positive Results from the...
EXL Reports 2024 First Quarter Results
May 02, 2024 06:00 ET
|
ExlService Holdings, Inc.
2024 First Quarter Revenue of $436.5 Million, up 9.0% year-over-yearQ1 Diluted EPS (GAAP) (1) of $0.29, down 3.3% from $0.30 in Q1 of 2023Q1 Adjusted Diluted EPS (Non-GAAP) (1) (2) of $0.38, up 8.9%...
Ansys Announces Q1 Financial Results
May 01, 2024 16:30 ET
|
ANSYS, Inc.
/ Q1 2024 Results Revenue of $466.6 millionGAAP diluted earnings per share of $0.40 and non-GAAP diluted earnings per share of $1.39GAAP operating profit margin of 9.3% and non-GAAP operating profit...
Enact Reports First Quarter 2024 Results
May 01, 2024 16:20 ET
|
Enact Holdings, Inc.
GAAP Net Income of $161 million, or $1.01 per diluted shareAdjusted Operating Income of $166 million, or $1.04 per diluted shareReturn on Equity of 13.8% and Adjusted Operating Return on Equity of...
MYR Group Inc. Announces First-Quarter 2024 Results
May 01, 2024 16:13 ET
|
MYR Group, Inc.
THORNTON, Colo., May 01, 2024 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial...
New York Mortgage Trust Reports First Quarter 2024 Results
May 01, 2024 16:10 ET
|
New York Mortgage Trust, Inc.
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (“NYMT,” the “Company,” “we,” “our” or “us”) today reported results for the three months ended March 31, 2024....